Next Article in Journal
Estimating All-Cause Deaths Averted in the First Two Years of the COVID-19 Vaccination Campaign in Italy
Next Article in Special Issue
Further Evaluation of Enterohemorrhagic Escherichia coli Gold Nanoparticle Vaccines Utilizing Citrobacter rodentium as the Model Organism
Previous Article in Journal
Lineage Replacement and Genetic Changes of Four HR-HPV Types during the Period of Vaccine Coverage: A Six-Year Retrospective Study in Eastern China
Previous Article in Special Issue
Recombinant Salmonella gallinarum (S. gallinarum) Vaccine Candidate Expressing Avian Pathogenic Escherichia coli Type I Fimbriae Provides Protections against APEC O78 and O161 Serogroups and S. gallinarum Infection
 
 
Article

Article Versions Notes

Vaccines 2024, 12(4), 412; https://doi.org/10.3390/vaccines12040412
Action Date Notes Link
article xml file uploaded 12 April 2024 17:01 CEST Original file -
article xml uploaded. 12 April 2024 17:01 CEST Update https://www.mdpi.com/2076-393X/12/4/412/xml
article pdf uploaded. 12 April 2024 17:01 CEST Version of Record https://www.mdpi.com/2076-393X/12/4/412/pdf
article html file updated 12 April 2024 17:05 CEST Original file https://www.mdpi.com/2076-393X/12/4/412/html
Back to TopTop